Skip to main content

Table 4 Results of JCRG’s Integrated Consignment Screening Test at postoperative day 16

From: Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report

Variable

Results

Reference range

a2-Plasmin inhibitor (%)

63%

85–115

PIC (mg/mL)

< 0.3 mg/mL

< 0.8

FDP (mg/mL)

19 mg/mL

< 4

D-dimer (mg/mL)

13.56 mg/mL

< 1.0

Fibrinogen (mg/dL)

158 mg/dL

150–400

FXIII/13 antigen (%)

59%

70–140

VWF antigen (%)

205%

50–155

Plasminogen (%)

51%

75–125

E-XDP (mg/mL)

38.6 mg/mL

Total PAI (ng/mL)

99 ng/mL

< 50

FXIII/13 activity (%)

69%

70–140

VWF Rco activity (%)

272%

60–170

FV/5 activity (%)

< 3%

70–135

FVIII/8 activity (%)

< 1%

60–150

FX/10 activity (%)

< 3%

70–130

  1. PIC plasmin–plasmin inhibitor complex, FDP fibrin/fibrinogen degradation products, VWF von Willebrand factor, E-XDP elastase-digested cross-linked fibrin degradation products, PAI plasminogen activator inhibitor type-I, Rco ristocetin cofactor